Variant report
Variant | nsv983758 |
---|---|
Chromosome Location | chr13:64242199-64249400 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531529449 | chr13:64242825-64242826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577520908 | chr13:64242882-64242883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562597408 | chr13:64242903-64242904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs981289 | chr13:64242934-64242935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs370414559 | chr13:64242999-64243000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74880438 | chr13:64243004-64243005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145009950 | chr13:64243015-64243016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527618211 | chr13:64243024-64243025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552485918 | chr13:64243077-64243078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570503830 | chr13:64243083-64243084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73500796 | chr13:64243094-64243095 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs553621422 | chr13:64243121-64243122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1443960 | chr13:64243174-64243175 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs536872667 | chr13:64243177-64243178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554890222 | chr13:64243180-64243181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567035816 | chr13:64243234-64243235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192801095 | chr13:64243264-64243265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35272428 | chr13:64243267-64243268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558818947 | chr13:64243272-64243273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576832871 | chr13:64243449-64243450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544162106 | chr13:64243511-64243512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556256862 | chr13:64243522-64243523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563176436 | chr13:64243557-64243558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574813000 | chr13:64243569-64243570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112790343 | chr13:64243606-64243607 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542288012 | chr13:64243622-64243623 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201782965 | chr13:64243653-64243654 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138786335 | chr13:64243713-64243714 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546167891 | chr13:64243779-64243780 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184348513 | chr13:64243848-64243849 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561883248 | chr13:64243855-64243856 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575351654 | chr13:64243856-64243857 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9570976 | chr13:64243870-64243871 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372162663 | chr13:64243897-64243898 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549773852 | chr13:64243990-64243991 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117595685 | chr13:64244006-64244007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376850069 | chr13:64244037-64244038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189845797 | chr13:64244090-64244091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141121154 | chr13:64244094-64244095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150176996 | chr13:64244146-64244147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12868397 | chr13:64244241-64244242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9570977 | chr13:64244243-64244244 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs558834743 | chr13:64244270-64244271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117152452 | chr13:64244283-64244284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112097640 | chr13:64244290-64244291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556311358 | chr13:64244331-64244332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148300662 | chr13:64244375-64244376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184383387 | chr13:64245206-64245207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79160639 | chr13:64245228-64245229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143475372 | chr13:64245268-64245269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64242800-64243600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr13:64243200-64244000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:64243400-64244000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:64243600-64244000 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr13:64243600-64244000 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
6 | chr13:64243600-64244400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr13:64245200-64247400 | Enhancers | Fetal Lung | lung |